Review



anti-hpv16/18 e6 sc-460  (Santa Cruz Biotechnology)


Bioz Verified Symbol Santa Cruz Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Santa Cruz Biotechnology anti-hpv16/18 e6 sc-460
    Anti Hpv16/18 E6 Sc 460, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-hpv16/18 e6 sc-460/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    anti-hpv16/18 e6 sc-460 - by Bioz Stars, 2026-02
    90/100 stars

    Images



    Similar Products

    90
    Arbor Vita anti-hpv16 e6 avc 843
    Anti Hpv16 E6 Avc 843, supplied by Arbor Vita, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-hpv16 e6 avc 843/product/Arbor Vita
    Average 90 stars, based on 1 article reviews
    anti-hpv16 e6 avc 843 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology anti-hpv16/18 e6 sc-460
    Anti Hpv16/18 E6 Sc 460, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-hpv16/18 e6 sc-460/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    anti-hpv16/18 e6 sc-460 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    94
    Santa Cruz Biotechnology anti hpv16 18 e6
    Anti Hpv16 18 E6, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti hpv16 18 e6/product/Santa Cruz Biotechnology
    Average 94 stars, based on 1 article reviews
    anti hpv16 18 e6 - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    94
    Santa Cruz Biotechnology anti hpv16 e6 antibody
    Anti Hpv16 E6 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti hpv16 e6 antibody/product/Santa Cruz Biotechnology
    Average 94 stars, based on 1 article reviews
    anti hpv16 e6 antibody - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    90
    GeneTex rabbit anti-hpv16-e6
    Rabbit Anti Hpv16 E6, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti-hpv16-e6/product/GeneTex
    Average 90 stars, based on 1 article reviews
    rabbit anti-hpv16-e6 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology hpv16 e6
    (A) Diagram of the E6E7 coding region of the HPV genome showing the unspliced (E6fl) and three spliced RNAs transcribed from the region (E6*I, E6*II, E6*X). P 97 , <t>HPV16</t> early promoter located at nucleotide 97 on the genome. Forward and reverse facing chevrons indicate the approximate position of the primers used in the PCR reaction in (B). (B) Gel image showing end point RT-PCR products using the primers indicated in (A) to amplify all four E6E7 mRNAs from NIKS16 cells differentiated in monolayer culture and treated with DMSO or 10 µM SRPIN340. M = size marker. Western blot of levels of (C) E6 and (E) E7 in monolayer cultured and differentiated NIKS16 cells either mock-treated or treated with DMSO, or SRPIN340 at 10 µM or 50 µM. Differentiated HPV-negative NIKS cells extracts were included in each blot to show specificity of the antibodies. Cell extracts from HeLa cells grown in monolayer culture were included on the blot as a positive control for detection of E6 and E7. The antibodies against E6 and E7 detect both HPV16 and HPV18 oncoproteins. The upper portion of each blot was reacted with an anti β-tubulin antibody as a loading control. Graphs showing quantification of three separate western blot experiments of the levels of (D) E6 and (F) E7 relative to β-tubulin, in NIKS16 cells differentiated in monolayer culture using the various experimental conditions in the western blots. (G) Western blots of levels of Rb, p53 and GAPDH as a loading control, in differentiated monolayer-cultured NIKS16 cells mock-treated or treated with DMSO, or SRPIN340 at 10 µM or 50 µM. H. Graph showing quantification of p53 and Rb levels in the western blot in (G). Expression levels were calculated relative to the GAPDH loading control. The data in all the graphs are the mean and standard deviation from the mean from three separate experiments. ns, not statistically significant.
    Hpv16 E6, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hpv16 e6/product/Santa Cruz Biotechnology
    Average 93 stars, based on 1 article reviews
    hpv16 e6 - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology anti-hpv16 e6/18 e6 sc-460
    (A) Diagram of the E6E7 coding region of the HPV genome showing the unspliced (E6fl) and three spliced RNAs transcribed from the region (E6*I, E6*II, E6*X). P 97 , <t>HPV16</t> early promoter located at nucleotide 97 on the genome. Forward and reverse facing chevrons indicate the approximate position of the primers used in the PCR reaction in (B). (B) Gel image showing end point RT-PCR products using the primers indicated in (A) to amplify all four E6E7 mRNAs from NIKS16 cells differentiated in monolayer culture and treated with DMSO or 10 µM SRPIN340. M = size marker. Western blot of levels of (C) E6 and (E) E7 in monolayer cultured and differentiated NIKS16 cells either mock-treated or treated with DMSO, or SRPIN340 at 10 µM or 50 µM. Differentiated HPV-negative NIKS cells extracts were included in each blot to show specificity of the antibodies. Cell extracts from HeLa cells grown in monolayer culture were included on the blot as a positive control for detection of E6 and E7. The antibodies against E6 and E7 detect both HPV16 and HPV18 oncoproteins. The upper portion of each blot was reacted with an anti β-tubulin antibody as a loading control. Graphs showing quantification of three separate western blot experiments of the levels of (D) E6 and (F) E7 relative to β-tubulin, in NIKS16 cells differentiated in monolayer culture using the various experimental conditions in the western blots. (G) Western blots of levels of Rb, p53 and GAPDH as a loading control, in differentiated monolayer-cultured NIKS16 cells mock-treated or treated with DMSO, or SRPIN340 at 10 µM or 50 µM. H. Graph showing quantification of p53 and Rb levels in the western blot in (G). Expression levels were calculated relative to the GAPDH loading control. The data in all the graphs are the mean and standard deviation from the mean from three separate experiments. ns, not statistically significant.
    Anti Hpv16 E6/18 E6 Sc 460, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-hpv16 e6/18 e6 sc-460/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    anti-hpv16 e6/18 e6 sc-460 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    Image Search Results


    (A) Diagram of the E6E7 coding region of the HPV genome showing the unspliced (E6fl) and three spliced RNAs transcribed from the region (E6*I, E6*II, E6*X). P 97 , HPV16 early promoter located at nucleotide 97 on the genome. Forward and reverse facing chevrons indicate the approximate position of the primers used in the PCR reaction in (B). (B) Gel image showing end point RT-PCR products using the primers indicated in (A) to amplify all four E6E7 mRNAs from NIKS16 cells differentiated in monolayer culture and treated with DMSO or 10 µM SRPIN340. M = size marker. Western blot of levels of (C) E6 and (E) E7 in monolayer cultured and differentiated NIKS16 cells either mock-treated or treated with DMSO, or SRPIN340 at 10 µM or 50 µM. Differentiated HPV-negative NIKS cells extracts were included in each blot to show specificity of the antibodies. Cell extracts from HeLa cells grown in monolayer culture were included on the blot as a positive control for detection of E6 and E7. The antibodies against E6 and E7 detect both HPV16 and HPV18 oncoproteins. The upper portion of each blot was reacted with an anti β-tubulin antibody as a loading control. Graphs showing quantification of three separate western blot experiments of the levels of (D) E6 and (F) E7 relative to β-tubulin, in NIKS16 cells differentiated in monolayer culture using the various experimental conditions in the western blots. (G) Western blots of levels of Rb, p53 and GAPDH as a loading control, in differentiated monolayer-cultured NIKS16 cells mock-treated or treated with DMSO, or SRPIN340 at 10 µM or 50 µM. H. Graph showing quantification of p53 and Rb levels in the western blot in (G). Expression levels were calculated relative to the GAPDH loading control. The data in all the graphs are the mean and standard deviation from the mean from three separate experiments. ns, not statistically significant.

    Journal: PLOS Pathogens

    Article Title: The splicing factor kinase, SR protein kinase 1 (SRPK1) is essential for late events in the human papillomavirus life cycle

    doi: 10.1371/journal.ppat.1012697

    Figure Lengend Snippet: (A) Diagram of the E6E7 coding region of the HPV genome showing the unspliced (E6fl) and three spliced RNAs transcribed from the region (E6*I, E6*II, E6*X). P 97 , HPV16 early promoter located at nucleotide 97 on the genome. Forward and reverse facing chevrons indicate the approximate position of the primers used in the PCR reaction in (B). (B) Gel image showing end point RT-PCR products using the primers indicated in (A) to amplify all four E6E7 mRNAs from NIKS16 cells differentiated in monolayer culture and treated with DMSO or 10 µM SRPIN340. M = size marker. Western blot of levels of (C) E6 and (E) E7 in monolayer cultured and differentiated NIKS16 cells either mock-treated or treated with DMSO, or SRPIN340 at 10 µM or 50 µM. Differentiated HPV-negative NIKS cells extracts were included in each blot to show specificity of the antibodies. Cell extracts from HeLa cells grown in monolayer culture were included on the blot as a positive control for detection of E6 and E7. The antibodies against E6 and E7 detect both HPV16 and HPV18 oncoproteins. The upper portion of each blot was reacted with an anti β-tubulin antibody as a loading control. Graphs showing quantification of three separate western blot experiments of the levels of (D) E6 and (F) E7 relative to β-tubulin, in NIKS16 cells differentiated in monolayer culture using the various experimental conditions in the western blots. (G) Western blots of levels of Rb, p53 and GAPDH as a loading control, in differentiated monolayer-cultured NIKS16 cells mock-treated or treated with DMSO, or SRPIN340 at 10 µM or 50 µM. H. Graph showing quantification of p53 and Rb levels in the western blot in (G). Expression levels were calculated relative to the GAPDH loading control. The data in all the graphs are the mean and standard deviation from the mean from three separate experiments. ns, not statistically significant.

    Article Snippet: Membranes were incubated with primary antibody diluted in PBS-T (PBS with 0.1% Tween) containing 5% FBS overnight at 4 o C before being washed three times with PBS-T. Primary antibodies were SRSF1 (1:1000, Mab96, Thermo Fisher Scientific, catalogue # 32-4500), SRSF2 (1:1000, Abcam, catalogue #Ab204916), SRSF3 (1:500, Life Technologies, UK, catalogue #334200), SRPK1 (1:500, clone G211-637 BD Transduction Laboratories, catalogue #611072), α-tubulin (1:5000, clone A11126, Thermo Fisher Scientific catalogue # 236-10501), involucrin (1:1000 clone SY5, Merck, UK, catalogue #19018), GAPDH (1:1000, Meridian Life Sciences, UK, catalogue #H86504M, clone 6C5), HPV16 E2 (1:500 Santa Cruz, Germany, catalogue #sc-53327, TVG271), HPV16 E6 (1:500, Santa Cruz, Germany, catalogue # sc-365089), HPV16 E7 (1:500 Santa Cruz, Germany, catalogue #sc-51951), HPV16 L1 (1:500 Dako, Denmark, clone K1H8), p53 (1:700, BD Pharmingen, UK, catalogue #554294), Rb (1:500, Cell Signaling Technologies, Germany, catalogue #9309, clone 4H1), MCM2 (1:500, Abcam, UK, catalogue #Ab133325), Ki67 (1:1000, Abcam, UK, catalogue #Ab197234), keratin 10 (1:500, Abcam, UK, catalogue #Ab9025).

    Techniques: Reverse Transcription Polymerase Chain Reaction, Marker, Western Blot, Cell Culture, Positive Control, Control, Expressing, Standard Deviation

    (A) Diagram of the portion of the HPV16 genome downstream of the P 670 late promoter located in the E7 gene region. The E1^E4^L1 alternatively spliced mRNA encodes E4 and L1 and the readthrough mRNA E1^E4, E5, L2 and L1 is thought to encode L2. These RNAs are diagrammed below the genome map. P 670 , HPV16 late promoter located at nucleotide 670. p(A)E, early polyadenylation site, p(A)L, late polyadenylation site. Open rectangles, HPV16 genes E1, E2, E4, E5, L2 and L1. Shaded rectangles, open reading frames in the RNAs. Dotted lines represent RNA sequences spliced out to form the mRNAs. AAAn, poly(A) tail. Chevrons indicate the approximate positions of forward and reverse primers used in the PCR reactions shown in (B) and (C). (B) Ethidium bromide-stained gel showing the PCR products obtained from amplification of cDNA prepared from monolayer cultured and differentiated NIKS16 cells using the primer pair indicated in (A) for the E1^E4^L1 mRNA. GAPDH primer pairs were added to the same reaction for a loading control. * non-specific bands. (C) Upper panel: ethidium bromide-stained gel showing the PCR products obtained from amplification of cDNA prepared from monolayer cultured and differentiated NIKS16 cells using the primer pairs indicated in (A) in a nested PCR reaction to amplify across the L2-L1 junction from the E1^E4, E5, L2, L1 readthrough mRNA. Lower panel: amplification of GAPDH as a loading control. In (B) and (C) the gel pictures are split because additional reactions were electrophoresed between the marker lane and the DMSO and SRPIN340 lanes.

    Journal: PLOS Pathogens

    Article Title: The splicing factor kinase, SR protein kinase 1 (SRPK1) is essential for late events in the human papillomavirus life cycle

    doi: 10.1371/journal.ppat.1012697

    Figure Lengend Snippet: (A) Diagram of the portion of the HPV16 genome downstream of the P 670 late promoter located in the E7 gene region. The E1^E4^L1 alternatively spliced mRNA encodes E4 and L1 and the readthrough mRNA E1^E4, E5, L2 and L1 is thought to encode L2. These RNAs are diagrammed below the genome map. P 670 , HPV16 late promoter located at nucleotide 670. p(A)E, early polyadenylation site, p(A)L, late polyadenylation site. Open rectangles, HPV16 genes E1, E2, E4, E5, L2 and L1. Shaded rectangles, open reading frames in the RNAs. Dotted lines represent RNA sequences spliced out to form the mRNAs. AAAn, poly(A) tail. Chevrons indicate the approximate positions of forward and reverse primers used in the PCR reactions shown in (B) and (C). (B) Ethidium bromide-stained gel showing the PCR products obtained from amplification of cDNA prepared from monolayer cultured and differentiated NIKS16 cells using the primer pair indicated in (A) for the E1^E4^L1 mRNA. GAPDH primer pairs were added to the same reaction for a loading control. * non-specific bands. (C) Upper panel: ethidium bromide-stained gel showing the PCR products obtained from amplification of cDNA prepared from monolayer cultured and differentiated NIKS16 cells using the primer pairs indicated in (A) in a nested PCR reaction to amplify across the L2-L1 junction from the E1^E4, E5, L2, L1 readthrough mRNA. Lower panel: amplification of GAPDH as a loading control. In (B) and (C) the gel pictures are split because additional reactions were electrophoresed between the marker lane and the DMSO and SRPIN340 lanes.

    Article Snippet: Membranes were incubated with primary antibody diluted in PBS-T (PBS with 0.1% Tween) containing 5% FBS overnight at 4 o C before being washed three times with PBS-T. Primary antibodies were SRSF1 (1:1000, Mab96, Thermo Fisher Scientific, catalogue # 32-4500), SRSF2 (1:1000, Abcam, catalogue #Ab204916), SRSF3 (1:500, Life Technologies, UK, catalogue #334200), SRPK1 (1:500, clone G211-637 BD Transduction Laboratories, catalogue #611072), α-tubulin (1:5000, clone A11126, Thermo Fisher Scientific catalogue # 236-10501), involucrin (1:1000 clone SY5, Merck, UK, catalogue #19018), GAPDH (1:1000, Meridian Life Sciences, UK, catalogue #H86504M, clone 6C5), HPV16 E2 (1:500 Santa Cruz, Germany, catalogue #sc-53327, TVG271), HPV16 E6 (1:500, Santa Cruz, Germany, catalogue # sc-365089), HPV16 E7 (1:500 Santa Cruz, Germany, catalogue #sc-51951), HPV16 L1 (1:500 Dako, Denmark, clone K1H8), p53 (1:700, BD Pharmingen, UK, catalogue #554294), Rb (1:500, Cell Signaling Technologies, Germany, catalogue #9309, clone 4H1), MCM2 (1:500, Abcam, UK, catalogue #Ab133325), Ki67 (1:1000, Abcam, UK, catalogue #Ab197234), keratin 10 (1:500, Abcam, UK, catalogue #Ab9025).

    Techniques: Staining, Amplification, Cell Culture, Control, Nested PCR, Marker

    (A) Diagram of the early region of the HPV16 genome downstream of the E6E7 gene region. P 670 , HPV16 late promoter located at nucleotide 670 in the E7 coding region. p(A)E, the HPV16 early polyadenylation site. Open rectangles, HPV16 early genes E1, E2, E4, E5. Below is the genome map is shown a diagram of the major spliced mRNA encoding E2. Shaded rectangles, open reading frames. Dotted lines represent RNA sequences spliced out to form the E2 mRNA. AAAn, poly(A) tail. Black chevrons indicate forward and reverse primers used in the first round of the nested RT-PCR reaction shown in (B). A red split chevron indicates the forward primer used in the second round of the nested PCR amplification shown in (B). This cross-splice epitope primer was used with the reverse primer located inside the E2 open reading frame. SD880, splice donor site at nucleotide 880. SA2709, splice acceptor site at nucleotide 2709. (B) Upper panel: ethidium bromide-stained gel showing the products of an RT-PCR reaction to amplify the E2 mRNA from NIKS16 cells differentiated in monolayer and treated with DMSO (lane 1) or with SRPIN349 (lane 2), not inhibitory to SRPK1, or with SRPIN340 (lane 3). Lower panel: GAPDH cDNA was amplified as a loading control. The gel picture is split because the GAPDH reactions were electrophoresed on the right-hand side of the same gel used to visualise the E2 amplification products. These were electrophoresed on the left-hand side adjacent to the size markers. (C) Western blot showing levels of E2 in monolayer-cultured and partially differentiated NIKS16 cells (differentiated for six days) mock-treated, DMSO-treated or treated with either 10 µM or 50 µM SRPIN340 for 48 hours. Protein extract from HPV-negative differentiated monolayer-cultured NIKS cells was included in the experiment to demonstrate specificity of the E2 antibody. β-tubulin was used as a loading control. (D) Graph showing quantification of E2 levels relative to the β-tubulin loading controls in the various experimental conditions used in the western blot in (C). The data shown are the mean and standard deviation from the mean from quantification of three separate western blot experiments. p<0.05*, p-value indicating a significant difference in E2 expression levels. (E) Graph showing quantification of E2 levels relative to the β-tubulin loading controls using protein extracts from NIKS16 cells grown in differentiated 3D raft tissue cultures. The data shown are the mean and standard deviation from the mean from three separate western blot experiments Representative western blots showing E2 and β-tubulin levels are shown above the graph. p<0.05*, p-value indicating a significant difference in E2 expression levels. (F) Immunofluorescence staining with an E2 antibody (green staining, left hand panels) and counterstained with DAPI (blue staining, right hand panels) of sections of differentiated 3D cultured NIKS16 raft tissues topically treated with DMSO or with 10 µM SPRIN340. Dotted lines indicate the basal membrane of the tissues. Size bars=50 µm.

    Journal: PLOS Pathogens

    Article Title: The splicing factor kinase, SR protein kinase 1 (SRPK1) is essential for late events in the human papillomavirus life cycle

    doi: 10.1371/journal.ppat.1012697

    Figure Lengend Snippet: (A) Diagram of the early region of the HPV16 genome downstream of the E6E7 gene region. P 670 , HPV16 late promoter located at nucleotide 670 in the E7 coding region. p(A)E, the HPV16 early polyadenylation site. Open rectangles, HPV16 early genes E1, E2, E4, E5. Below is the genome map is shown a diagram of the major spliced mRNA encoding E2. Shaded rectangles, open reading frames. Dotted lines represent RNA sequences spliced out to form the E2 mRNA. AAAn, poly(A) tail. Black chevrons indicate forward and reverse primers used in the first round of the nested RT-PCR reaction shown in (B). A red split chevron indicates the forward primer used in the second round of the nested PCR amplification shown in (B). This cross-splice epitope primer was used with the reverse primer located inside the E2 open reading frame. SD880, splice donor site at nucleotide 880. SA2709, splice acceptor site at nucleotide 2709. (B) Upper panel: ethidium bromide-stained gel showing the products of an RT-PCR reaction to amplify the E2 mRNA from NIKS16 cells differentiated in monolayer and treated with DMSO (lane 1) or with SRPIN349 (lane 2), not inhibitory to SRPK1, or with SRPIN340 (lane 3). Lower panel: GAPDH cDNA was amplified as a loading control. The gel picture is split because the GAPDH reactions were electrophoresed on the right-hand side of the same gel used to visualise the E2 amplification products. These were electrophoresed on the left-hand side adjacent to the size markers. (C) Western blot showing levels of E2 in monolayer-cultured and partially differentiated NIKS16 cells (differentiated for six days) mock-treated, DMSO-treated or treated with either 10 µM or 50 µM SRPIN340 for 48 hours. Protein extract from HPV-negative differentiated monolayer-cultured NIKS cells was included in the experiment to demonstrate specificity of the E2 antibody. β-tubulin was used as a loading control. (D) Graph showing quantification of E2 levels relative to the β-tubulin loading controls in the various experimental conditions used in the western blot in (C). The data shown are the mean and standard deviation from the mean from quantification of three separate western blot experiments. p<0.05*, p-value indicating a significant difference in E2 expression levels. (E) Graph showing quantification of E2 levels relative to the β-tubulin loading controls using protein extracts from NIKS16 cells grown in differentiated 3D raft tissue cultures. The data shown are the mean and standard deviation from the mean from three separate western blot experiments Representative western blots showing E2 and β-tubulin levels are shown above the graph. p<0.05*, p-value indicating a significant difference in E2 expression levels. (F) Immunofluorescence staining with an E2 antibody (green staining, left hand panels) and counterstained with DAPI (blue staining, right hand panels) of sections of differentiated 3D cultured NIKS16 raft tissues topically treated with DMSO or with 10 µM SPRIN340. Dotted lines indicate the basal membrane of the tissues. Size bars=50 µm.

    Article Snippet: Membranes were incubated with primary antibody diluted in PBS-T (PBS with 0.1% Tween) containing 5% FBS overnight at 4 o C before being washed three times with PBS-T. Primary antibodies were SRSF1 (1:1000, Mab96, Thermo Fisher Scientific, catalogue # 32-4500), SRSF2 (1:1000, Abcam, catalogue #Ab204916), SRSF3 (1:500, Life Technologies, UK, catalogue #334200), SRPK1 (1:500, clone G211-637 BD Transduction Laboratories, catalogue #611072), α-tubulin (1:5000, clone A11126, Thermo Fisher Scientific catalogue # 236-10501), involucrin (1:1000 clone SY5, Merck, UK, catalogue #19018), GAPDH (1:1000, Meridian Life Sciences, UK, catalogue #H86504M, clone 6C5), HPV16 E2 (1:500 Santa Cruz, Germany, catalogue #sc-53327, TVG271), HPV16 E6 (1:500, Santa Cruz, Germany, catalogue # sc-365089), HPV16 E7 (1:500 Santa Cruz, Germany, catalogue #sc-51951), HPV16 L1 (1:500 Dako, Denmark, clone K1H8), p53 (1:700, BD Pharmingen, UK, catalogue #554294), Rb (1:500, Cell Signaling Technologies, Germany, catalogue #9309, clone 4H1), MCM2 (1:500, Abcam, UK, catalogue #Ab133325), Ki67 (1:1000, Abcam, UK, catalogue #Ab197234), keratin 10 (1:500, Abcam, UK, catalogue #Ab9025).

    Techniques: Reverse Transcription Polymerase Chain Reaction, Nested PCR, Amplification, Staining, Control, Western Blot, Cell Culture, Standard Deviation, Expressing, Immunofluorescence, Membrane

    (A) Heatmap of overall changes in gene expression caused by SRPIN340 treatment in NIKS16 cells differentiated in monolayer culture. Three replicates of DMSO-treated and 10 µM SRPIN340-treated NIKS16 cells were sequenced. (B) Pie chart showing the relative percentages of categories of SRPIN340 up-regulated genes in NIKS16 cells differentiated in monolayer culture. The GO terms for the up-regulated pathways are shown on the right-hand side. (C) Pie chart showing the relative percentages of categories of SRPIN340 down-regulated genes in NIKS16 cells differentiated in monolayer culture. The GO terms for the down-regulated pathways are shown on the right-hand side. (D) Graph showing genes involved in the epithelial structural barrier down-regulated by HPV16 infection but up-regulated by SRPIN340 treatment in NIKS16 cells differentiated in monolayer culture. (E) Graph showing genes involved in innate immunity oppositely regulated by HPV16 infection and SRPIN340 treatment of NIKS16 cells differentiated in monolayer culture. (F) Over representation analysis showing the various cellular processes altered by SRPIN340-induced changes in alternative splicing in the above experiment.

    Journal: PLOS Pathogens

    Article Title: The splicing factor kinase, SR protein kinase 1 (SRPK1) is essential for late events in the human papillomavirus life cycle

    doi: 10.1371/journal.ppat.1012697

    Figure Lengend Snippet: (A) Heatmap of overall changes in gene expression caused by SRPIN340 treatment in NIKS16 cells differentiated in monolayer culture. Three replicates of DMSO-treated and 10 µM SRPIN340-treated NIKS16 cells were sequenced. (B) Pie chart showing the relative percentages of categories of SRPIN340 up-regulated genes in NIKS16 cells differentiated in monolayer culture. The GO terms for the up-regulated pathways are shown on the right-hand side. (C) Pie chart showing the relative percentages of categories of SRPIN340 down-regulated genes in NIKS16 cells differentiated in monolayer culture. The GO terms for the down-regulated pathways are shown on the right-hand side. (D) Graph showing genes involved in the epithelial structural barrier down-regulated by HPV16 infection but up-regulated by SRPIN340 treatment in NIKS16 cells differentiated in monolayer culture. (E) Graph showing genes involved in innate immunity oppositely regulated by HPV16 infection and SRPIN340 treatment of NIKS16 cells differentiated in monolayer culture. (F) Over representation analysis showing the various cellular processes altered by SRPIN340-induced changes in alternative splicing in the above experiment.

    Article Snippet: Membranes were incubated with primary antibody diluted in PBS-T (PBS with 0.1% Tween) containing 5% FBS overnight at 4 o C before being washed three times with PBS-T. Primary antibodies were SRSF1 (1:1000, Mab96, Thermo Fisher Scientific, catalogue # 32-4500), SRSF2 (1:1000, Abcam, catalogue #Ab204916), SRSF3 (1:500, Life Technologies, UK, catalogue #334200), SRPK1 (1:500, clone G211-637 BD Transduction Laboratories, catalogue #611072), α-tubulin (1:5000, clone A11126, Thermo Fisher Scientific catalogue # 236-10501), involucrin (1:1000 clone SY5, Merck, UK, catalogue #19018), GAPDH (1:1000, Meridian Life Sciences, UK, catalogue #H86504M, clone 6C5), HPV16 E2 (1:500 Santa Cruz, Germany, catalogue #sc-53327, TVG271), HPV16 E6 (1:500, Santa Cruz, Germany, catalogue # sc-365089), HPV16 E7 (1:500 Santa Cruz, Germany, catalogue #sc-51951), HPV16 L1 (1:500 Dako, Denmark, clone K1H8), p53 (1:700, BD Pharmingen, UK, catalogue #554294), Rb (1:500, Cell Signaling Technologies, Germany, catalogue #9309, clone 4H1), MCM2 (1:500, Abcam, UK, catalogue #Ab133325), Ki67 (1:1000, Abcam, UK, catalogue #Ab197234), keratin 10 (1:500, Abcam, UK, catalogue #Ab9025).

    Techniques: Gene Expression, Infection, Alternative Splicing

    Number of sequencing reads and percent alignment to the  HPV16  and human genomes for each sample subjected to RNA sequencing.

    Journal: PLOS Pathogens

    Article Title: The splicing factor kinase, SR protein kinase 1 (SRPK1) is essential for late events in the human papillomavirus life cycle

    doi: 10.1371/journal.ppat.1012697

    Figure Lengend Snippet: Number of sequencing reads and percent alignment to the HPV16 and human genomes for each sample subjected to RNA sequencing.

    Article Snippet: Membranes were incubated with primary antibody diluted in PBS-T (PBS with 0.1% Tween) containing 5% FBS overnight at 4 o C before being washed three times with PBS-T. Primary antibodies were SRSF1 (1:1000, Mab96, Thermo Fisher Scientific, catalogue # 32-4500), SRSF2 (1:1000, Abcam, catalogue #Ab204916), SRSF3 (1:500, Life Technologies, UK, catalogue #334200), SRPK1 (1:500, clone G211-637 BD Transduction Laboratories, catalogue #611072), α-tubulin (1:5000, clone A11126, Thermo Fisher Scientific catalogue # 236-10501), involucrin (1:1000 clone SY5, Merck, UK, catalogue #19018), GAPDH (1:1000, Meridian Life Sciences, UK, catalogue #H86504M, clone 6C5), HPV16 E2 (1:500 Santa Cruz, Germany, catalogue #sc-53327, TVG271), HPV16 E6 (1:500, Santa Cruz, Germany, catalogue # sc-365089), HPV16 E7 (1:500 Santa Cruz, Germany, catalogue #sc-51951), HPV16 L1 (1:500 Dako, Denmark, clone K1H8), p53 (1:700, BD Pharmingen, UK, catalogue #554294), Rb (1:500, Cell Signaling Technologies, Germany, catalogue #9309, clone 4H1), MCM2 (1:500, Abcam, UK, catalogue #Ab133325), Ki67 (1:1000, Abcam, UK, catalogue #Ab197234), keratin 10 (1:500, Abcam, UK, catalogue #Ab9025).

    Techniques: Sequencing